Cancer Research UK logo.
Search
  • Search
Convergence Science Centre Shoot 2023.

Current research into bowel cancer

Saving lives through our research

We’re tackling bowel cancer from all angles – understanding the underlying biology of the disease, finding new ways to prevent it in the first place, and testing new treatments in clinical trials. Below are some examples of what our researchers are doing right now.

Our current researchers

Preventing cancer using aspirin

Lynch syndrome is a condition that runs in families and puts people at a higher risk of developing bowel, womb and other types of cancer. There is strong evidence that aspirin can prevent cancers in this group of people. Professor Sir John Burn in Newcastle is leading a clinical trial testing if lower doses of aspirin work as well as higher doses, but with fewer side effects.

Read more about Lynch syndrome

Tracking bowel cancer from the beginning

Professor Owen Sansom is Director of our CRUK Scotland Institute (formerly the Beatson Institute) in Glasgow, where he's bringing together a European-wide consortium at the forefront of bowel cancer research. He hopes to accelerate the drug development pipeline – identifying new and repurposed drugs that can be used to combat different subtypes of bowel cancer. They hope to design clinical trials to test these personalised treatments in bowel cancer, to ensure no therapeutic opportunities are overlooked. 

Take a look at the cells Professor Sansom is studying

Investigating the benefits of exercise

In Belfast, Dr Vicky Coyle is leading the UK part of an international trial called the CHALLENGE trial. It’s looking at whether physical exercise could help reduce the risk of bowel cancer coming back after surgery and chemotherapy. The trial is supported by Stand Up To Cancer. 

Read more about her research in this blog post

Exploring aspirin's possibilities

We’re jointly funding a large international trial, called Add Aspirin, to see if aspirin can stop or delay bowel and other cancers coming back after treatment. It’s led by Professor Ruth Langley in London. The trial will help researchers work out who is most likely to benefit from taking aspirin, and how best to use it in cancer medicine.

Read more about Add Aspirin

Manchester Laboratory Image - Brand shoot 2024.

Past research

Thanks to research, we've helped change the outlook for people with bowel cancer.

Find out more about past research

Explore our timeline of research into bowel cancer

A picture of Amanda smiling and being embraced.

Patients' stories

Meet people like Amanda who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.

Read stories from bowel cancer patients

Further information

Want to find more information about our research or bowel cancer?

Find out more about clinical trials

More about the symptoms and treatments for bowel cancer